Proactively preventing dangerous diseases is essential to maintaining good health. Healthcare is not just about treating illnesses when they arise but also about taking active steps to protect yourself and your family from potential health risks. To help you and your loved ones stay protected, FV Hospital introduces two new vaccines: Shingrix – for the prevention of shingles, and Bexsero –for the prevention of Meningococcal Group B disease. Here are the benefits these vaccines offer and why they are an excellent choice for you and your family.

1. Shingrix: A Breakthrough Vaccine for Shingles Prevention

Shingrix is a vaccine indicated for the prevention of shingles (Herpes Zoster), also known as shingles rash, and related complications such as postherpetic neuralgia (PHN). It is recommended for adults aged 50 and older, as well as individuals aged 18 and above who are at increased risk of developing shingles.

Shingrix is researched, developed, and manufactured by GlaxoSmithKline (GSK), a leading global pharmaceutical and biotechnology company, with the vaccine manufactured in Italy.

Target Groups for Vaccination:

Shingrix is recommended for adults aged 50 and older, as well as individuals aged 18 and above with weakened or suppressed immune systems due to medical conditions or treatment therapies.

Mechanism of Action:

Shingrix is a recombinant vaccine formulated as an injectable suspension containing the glycoprotein E (gE) antigen of the Varicella Zoster Virus (VZV). With its optimised formula and AS01 adjuvant system, Shingrix helps the body develop a strong and long-lasting immune response, providing effective protection against shingles (Herpes Zoster).

Vaccination Schedule:

• For individuals aged 50 and above: Two doses, administered 2 months apart.
• For individuals aged 18 and above at high risk: Two doses, administered 1 month apart.

Possible Side Effects:

• For individuals aged 50 and above: Common side effects include local reactions at the injection site such as pain, swelling, and redness. Systemic reactions may include muscle pain, fatigue, headache, chills, fever, and gastrointestinal symptoms.
• For individuals aged 18 and older who have undergone autologous hematopoietic stem cell transplantation: Side effects often include pain, redness, and swelling at the injection site, along with fatigue, muscle pain, headache, chills, fever, and other gastrointestinal symptoms.

The SHINGRIX vaccine (GSK – Italy) at FV Hospital is priced at 5,057,000 VND/ dose (*).

2. Bexsero: Protection Against Meningococcal Group B Disease

Meningococcal Group B is a serious bacterial infection that can cause meningitis and sepsis, potentially leading to severe complications such as hearing loss, brain damage, or even death. This disease can develop suddenly and affect people of all ages, though it is particularly common among children, adolescents, and young adults.

Bexsero is a vaccine developed by GlaxoSmithKline (GSK) and manufactured in Italy. It has been approved by the Ministry of Health for the prevention of invasive meningococcal disease caused by Neisseria meningitidis group B.

Bexsero is indicated for immunization from infancy to adulthood, specifically for individuals aged 2 months to 50 years old (up to but not including their 51st birthday). The vaccine provides up to 95% effectiveness in protecting against invasive meningococcal disease caused by Neisseria meningitidis group B.

Target Groups for Vaccination:

Bexsero is indicated for children from 2 months of age to adults under 51 years old, providing up to 95% effectiveness in preventing Meningococcal Group B disease.

Mechanism of Action:

Bexsero helps the body develop strong immunity against Neisseria meningitidis group B, providing protection against the severe complications of the disease.

Recommended Vaccination Schedule for Bexsero (as per the Ministry of Health)

• Infants from 2 to under 6 months: Two primary doses at least 2 months apart, followed by a booster dose after 12 months.
• Infants from 6 to under 12 months: Two primary doses at least 2 months apart, followed by a booster dose after 2 months.
• Children from 1 to under 2 years: Two primary doses at least 2 months apart, followed by a booster dose after 12 months.
• Children from 2 years to adults under 51 years: Two primary doses at least 1 month apart.

Possible Side Effects of Bexsero

• In infants and young children under 10 years old: Common reactions include pain, swelling, redness, and hardening at the injection site, as well as fever, irritability, and reduced appetite.
• In adolescents 11 years and older and adults: Common side effects include pain, swelling, redness, and hardening at the injection site, along with discomfort and headache. The frequency and severity of side effects do not increase with subsequent doses in the vaccination series.

Bexsero Vaccine (GSK – Italy) at FV Hospital is priced at 2,667,000 VND/ dose (*).

Why Choose FV Hospital for Vaccinations?

• Vaccines are sourced from reputable manufacturers with guaranteed expiration dates.
• Standardised storage systems ensure vaccine safety and effectiveness.
• Dedicated medical professionals provide thorough consultations, addressing all questions about benefits and precautions.
• After vaccination, patients are monitored for 30 minutes to ensure safety.
• Clean, spacious vaccination rooms offer a quiet and comfortable environment for patients.

Take proactive steps to protect your health and your family’s today!

(*) Note: Vaccine prices include consultation and administration fees.

Contact FV Hospital for Vaccination Appointments:
FV Hospital – 6 Nguyen Luong Bang, Tan Phu Ward, District 7, Ho Chi Minh City
Phone: (028) 5411 3333